Deucravacitinib in Moderate to Severe Plaque Psoriasis: Comorbidities and Use of Prior and Concomitant Medication in Patients Enrolled in the Phase 3 POETYK PSO-1 and PSO-2 Trials. J of Skin [Internet]. 2024 Nov. 18 [cited 2025 May 19];8(6):s428. Available from: https://skin.dermsquared.com/skin/article/view/3105